MMP‐12 was selected because its expression is increased in CRC,36 in patients with high MMP‐12 expression prognosis is associated with ITGB6 expression (Figure 5C), and MMP‐12 is commercially available. The gene discussed is MMP12; the disease is colorectal carcinoma.